Profile
| Metric | Value |
|---|---|
| Full Name | TScan Therapeutics, Inc. |
| Ticker | NASDAQ: TCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tscan.com |
| Employees | 200 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.09 | |
| Price, 1D Change | +4.33% | |
| $62M | ||
| - | ||
| - | ||
| 1.01 | ||
| $3M | ||
| Revenue, 1Y Change | -86.62% | |
| -$1.14 | ||
| EPS, 1Y Change | +16.29% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.14 | ||
| EPS Estimate | N/A | -$1.24 |
| EPS Est. Change | N/A | -9.27% |
| $2.82M | ||
| Revenue Estimate | N/A | $10.68M |
| Revenue Est. Change | N/A | +279.23% |
| Current Price | $1.09 | |
| Price Target | - | $6.00 |
| Price Tgt. Change | - | +453.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.61 | -$1.36 | +15.53% | |
| -$1.12 | -$1.14 | -1.51% | |
| -$1.24 | N/A | -9.27% | |
| -$1.00 | N/A | +11.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.85M | $21.05M | +24.92% | |
| $3.60M | $2.82M | -21.79% | |
| $10.68M | N/A | +279.23% | |
| $7.88M | N/A | +179.65% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.09 | |
| $1.55 | ||
| SMA 200 vs Price | +42.65% | |
| $1.19 | ||
| SMA 50 vs Price | +9.35% | |
| 1.01 | ||
| $0.09 | ||
| 48.57 | ||
| 80.12% | ||
| 90.87% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.82M | ||
| -$1.14 | ||
| -$1.29M | ||
| -45.88% | ||
| -$134.82M | ||
| -4,787.68% | ||
| -$127.50M | ||
| -4,527.66% | ||
| -$119.74M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.40 | ||
| 8.14 | ||
| 8.14 | ||
| - | ||
| 2 | ||
| -1.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.31 | ||
| 0.43 | ||
| 0.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $240.97M | ||
| $178.69M | ||
| $371.12M | ||
| $292.72M | ||
| $130.15M | ||
| $35.96M | ||
| $97.38M | ||
| $4.57M | ||
| $4.28M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $137.64M | ||
| $137.64M | ||
| $4.11M | ||
| $29.56M | ||
| $4.11M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$110.82M | ||
| -$52.61M | ||
| $208.77M | ||
| $3.83M | ||
| -$114.65M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with TCRX
Data Sources & References
- TCRX Official Website www.tscan.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1783328/000119312525275933/0001193125-25-275933-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1783328/000095017025033077/0000950170-25-033077-index.htm
- TCRX Profile on Yahoo Finance finance.yahoo.com/quote/TCRX
- TCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tcrx
FAQ
What is the ticker symbol for TScan Therapeutics, Inc.?
The ticker symbol for TScan Therapeutics, Inc. is NASDAQ:TCRX
Does TScan Therapeutics, Inc. pay dividends?
No, TScan Therapeutics, Inc. does not pay dividends
What sector is TScan Therapeutics, Inc. in?
TScan Therapeutics, Inc. is in the Healthcare sector
What industry is TScan Therapeutics, Inc. in?
TScan Therapeutics, Inc. is in the Biotechnology industry
What country is TScan Therapeutics, Inc. based in?
TScan Therapeutics, Inc. is headquartered in United States
When did TScan Therapeutics, Inc. go public?
TScan Therapeutics, Inc. initial public offering (IPO) was on July 16, 2021
Is TScan Therapeutics, Inc. in the S&P 500?
No, TScan Therapeutics, Inc. is not included in the S&P 500 index
Is TScan Therapeutics, Inc. in the NASDAQ 100?
No, TScan Therapeutics, Inc. is not included in the NASDAQ 100 index
Is TScan Therapeutics, Inc. in the Dow Jones?
No, TScan Therapeutics, Inc. is not included in the Dow Jones index
When was TScan Therapeutics, Inc. last earnings report?
TScan Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does TScan Therapeutics, Inc. report earnings?
The date for TScan Therapeutics, Inc.'s next earnings report has not been announced yet